Impact of National Heart, Lung, and Blood Institute-Supported Cardiovascular Epidemiology Research, 1998 to 2012

Overview

Journal Circulation

Specialty Cardiology & Vascular Diseases

Date 2015 Oct 29

PMID 26508730

Citations 3

Authors

Richard R Fabsitz

George J Papanicolaou

Phyliss Sholinsky

Sean A Coady

Cashell E Jaquish

Cheryl R Nelson

Jean L Olson

Mona A Puggal

Kevin L Purkiser

Pothur R Srinivas

Gina S Wei

Michael Wolz

Paul D Sorlie

Affiliations

Soon will be listed here.

Citing Articles

Fifty Years of Progress in the Epidemiology of Chronic Obstructive Pulmonary Disease: A Review of National Heart, Lung, and Blood Institute-Sponsored Studies.

Mannino D Chronic Obstr Pulm Dis. 2019; 6(4).

PMID: 31647857 PMC: 7006703. DOI: 10.15326/jcopdf.6.4.2019.0145.

Efficient design of clinical trials and epidemiological research: is it possible?.

Lauer M, Gordon D, Wei G, Pearson G Nat Rev Cardiol. 2017; 14(8):493-501.

PMID: 28447664 DOI: 10.1038/nrcardio.2017.60.

Methodological Rigor in Preclinical Cardiovascular Studies: Targets to Enhance Reproducibility and Promote Research Translation.

Ramirez F, Motazedian P, Jung R, Di Santo P, MacDonald Z, Moreland R Circ Res. 2017; 120(12):1916-1926.

PMID: 28373349 PMC: 5466021. DOI: 10.1161/CIRCRESAHA.117.310628.

References

Sorlie P, Bild D, Lauer M . Cardiovascular epidemiology in a changing world--challenges to investigators and the National Heart, Lung, and Blood Institute. Am J Epidemiol. 2012; 175(7):597-601. PMC: 3390031. DOI: 10.1093/aje/kws138. View

Casadevall A, Fang F . Reforming science: methodological and cultural reforms. Infect Immun. 2011; 80(3):891-6. PMC: 3294645. DOI: 10.1128/IAI.06183-11. View

Langer J . Enabling scientific innovation. Science. 2012; 338(6104):171. DOI: 10.1126/science.1230947. View

Lauer M . Time for a creative transformation of epidemiology in the United States. JAMA. 2012; 308(17):1804-5. DOI: 10.1001/jama.2012.14838. View

Zoghbi H . The basics of translation. Science. 2013; 339(6117):250. DOI: 10.1126/science.1234799. View

Khoury M, Lam T, Ioannidis J, Hartge P, Spitz M, Buring J . Transforming epidemiology for 21st century medicine and public health. Cancer Epidemiol Biomarkers Prev. 2013; 22(4):508-16. PMC: 3625652. DOI: 10.1158/1055-9965.EPI-13-0146. View

Gordon D, Taddei-Peters W, Mascette A, Antman M, Kaufmann P, Lauer M . Publication of trials funded by the National Heart, Lung, and Blood Institute. N Engl J Med. 2013; 369(20):1926-34. PMC: 3928673. DOI: 10.1056/NEJMsa1300237. View

Puggal M, Schully S, Srinivas P, Papanicolaou G, Jaquish C, Fabsitz R . Translation of genetics research to clinical medicine: the National Heart, Lung, and Blood Institute perspective. Circ Cardiovasc Genet. 2013; 6(6):634-9. PMC: 3957221. DOI: 10.1161/CIRCGENETICS.113.000227. View

Chakma J, Sun G, Steinberg J, Sammut S, Jagsi R . Asia's ascent--global trends in biomedical R&D expenditures. N Engl J Med. 2014; 370(1):3-6. DOI: 10.1056/NEJMp1311068. View

10.

Mervis J . Peering into peer review. Science. 2014; 343(6171):596-8. DOI: 10.1126/science.343.6171.596. View

11.

Danthi N, Wu C, Shi P, Lauer M . Percentile ranking and citation impact of a large cohort of National Heart, Lung, and Blood Institute-funded cardiovascular R01 grants. Circ Res. 2014; 114(4):600-6. PMC: 3959724. DOI: 10.1161/CIRCRESAHA.114.302656. View

12.

Oh Y, Galis Z . Anatomy of success: the top 100 cited scientific reports focused on hypertension research. Hypertension. 2014; 63(4):641-7. PMC: 3954897. DOI: 10.1161/HYPERTENSIONAHA.113.02677. View

13.

Alberts B, Kirschner M, Tilghman S, Varmus H . Rescuing US biomedical research from its systemic flaws. Proc Natl Acad Sci U S A. 2014; 111(16):5773-7. PMC: 4000813. DOI: 10.1073/pnas.1404402111. View

14.

Roth J, Etzioni R, Waters T, Pettinger M, Rossouw J, Anderson G . Economic return from the Women's Health Initiative estrogen plus progestin clinical trial: a modeling study. Ann Intern Med. 2014; 160(9):594-602. PMC: 4157355. DOI: 10.7326/M13-2348. View

15.

Galis Z, Hoots W, Kiley J, Lauer M . On the value of portfolio diversity in heart, lung, and blood research. Am J Respir Crit Care Med. 2012; 186(7):575-8. PMC: 3480520. DOI: 10.1164/rccm.201208-1437ED. View

16.

Sorlie P, Wei G . Population-based cohort studies: still relevant?. J Am Coll Cardiol. 2011; 58(19):2010-3. DOI: 10.1016/j.jacc.2011.08.020. View

17.

Lenfant C . Shattuck lecture--clinical research to clinical practice--lost in translation?. N Engl J Med. 2003; 349(9):868-74. DOI: 10.1056/NEJMsa035507. View

18.

ODonnell C, Nabel E . Cardiovascular genomics, personalized medicine, and the National Heart, Lung, and Blood Institute: part I: the beginning of an era. Circ Cardiovasc Genet. 2009; 1(1):51-7. PMC: 3097376. DOI: 10.1161/CIRCGENETICS.108.813337. View

19.

Lauer M . Thought exercises on accountability and performance measures at the National Heart, Lung, and Blood Institute (NHLBI): an invited commentary for circulation research. Circ Res. 2011; 108(4):405-9. DOI: 10.1161/RES.0b013e3182125662. View

20.

Ioannidis J, Tarone R, McLaughlin J . The false-positive to false-negative ratio in epidemiologic studies. Epidemiology. 2011; 22(4):450-6. DOI: 10.1097/EDE.0b013e31821b506e. View